New AncestryHealth features physician-ordered tests in CLIA labs

By LabPulse.com staff writers

October 15, 2019 -- Ancestry is adding genetic profiling to its offerings, with a focus on tests ordered by physicians and performed in CLIA-certified laboratories in the U.S.

The company's new AncestryHealth tests will complement its long-running AncestryDNA genealogy services. Health testing will be ordered by physicians and performed by independent CLIA-certified laboratories, the company noted in a statement. To complement testing, Ancestry will provide genetic counseling and other educational resources, along with reports that suggest how to act on the findings in consultation with health professionals. The new offerings may be accessed on a one-time basis or as part of a regular subscription service.

Smartphones displaying AncestryHealth
Ancestry is now offering AncestryHealth. Image courtesy of Ancestry.

Ancestry's move into health testing comes at a time of scrutiny of the quality and oversight of consumer genetic testing. Tests ordered directly by a consumer through a website are managed by third-party labs and regulated by the U.S. Food and Drug Administration, whereas physician-ordered tests are regulated by the U.S. Centers for Medicare and Medicaid Services' CLIA program. Experts have expressed concern that consumers don't realize the difference, and they have advised more education and physician involvement in interpreting results from genetic tests.

USPSTF calls for more BRCA1/2 genetic screening, testing
Broader recommendations on screening for BRCA1/2 genetic mutations published by the U.S. Preventive Services Task Force (USPSTF) on August 20 represent...
AACC: Labs grapple with 'double-edged sword' of direct-to-consumer testing
ANAHEIM, CA - Direct-to-consumer testing has great potential to get patients engaged about their health and to broaden access to medical information,...
LabCorp builds on consumer tests
LabCorp is now offering consumers the ability to buy tests online, get tested by a phlebotomist at a convenient location, and receive results through...
AMP's stance on consumer tests gets makeover
The Association for Molecular Pathology (AMP) has broadened the criteria it wants to see for clinically meaningful genomic tests for consumers in an updated...
AMP, CAP show labs what they need to include in CYP2C9 tests
Labs should be including a broad set of CYP2C9 alleles in their own genotype tests, according to new joint recommendations published May 7 by the...

Copyright © 2019 LabPulse.com

Last Updated np 10/15/2019 11:31:54 AM